Måndag 9 November | 16:22:51 Europe / Stockholm
Est. tid*
2027-07-21 07:30 Kvartalsrapport 2027-Q2
2027-04-22 07:30 Kvartalsrapport 2027-Q1
2027-02-11 07:30 Bokslutskommuniké 2026
2026-10-21 - Kvartalsrapport 2026-Q3
2026-07-22 - Kvartalsrapport 2026-Q2
2026-04-24 - X-dag ordinarie utdelning SECARE 0.28 SEK
2026-04-23 - Årsstämma
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-12 - Bokslutskommuniké 2025
2025-10-22 - Kvartalsrapport 2025-Q3
2025-07-23 - Kvartalsrapport 2025-Q2
2025-04-25 - X-dag ordinarie utdelning SECARE 0.25 SEK
2025-04-24 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-23 - Kvartalsrapport 2024-Q3
2024-07-25 - Kvartalsrapport 2024-Q2
2024-04-26 - X-dag ordinarie utdelning SECARE 0.23 SEK
2024-04-25 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-07-27 - Kvartalsrapport 2023-Q2
2023-05-02 - X-dag ordinarie utdelning SECARE 0.22 SEK
2023-04-28 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-10-19 - Extra Bolagsstämma 2022
2022-07-28 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-29 - X-dag ordinarie utdelning SECARE 0.20 SEK
2022-04-28 - Årsstämma
2022-02-17 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-29 - Kvartalsrapport 2021-Q2
2021-05-24 - Split SECARE 1:5
2021-04-30 - X-dag ordinarie utdelning SECARE 0.80 SEK
2021-04-29 - Årsstämma
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-09-11 - Extra Bolagsstämma 2020
2020-07-24 - Kvartalsrapport 2020-Q2
2020-04-22 - X-dag ordinarie utdelning SECARE 0.70 SEK
2020-04-21 - Årsstämma
2020-04-21 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-07-26 - Kvartalsrapport 2019-Q2
2019-04-26 - X-dag ordinarie utdelning SECARE 0.00 SEK
2019-04-25 - Årsstämma
2019-04-25 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018
2018-10-25 - Kvartalsrapport 2018-Q3
2018-07-27 - Kvartalsrapport 2018-Q2
2018-04-26 - Kvartalsrapport 2018-Q1
2018-04-25 - X-dag ordinarie utdelning SECARE 0.00 SEK
2018-04-24 - Årsstämma
2018-02-22 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-04-28 - X-dag ordinarie utdelning SECARE 0.00 SEK
2017-04-27 - Årsstämma
2017-04-27 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Swedencare utvecklar, tillverkar och säljer premiumprodukter för den globala marknaden inom djurhälsa, med fokus på katter, hundar och hästar. Swedencares produktportfölj inkluderar varumärken såsom NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys® och ProDen PlaqueOff®. Bolaget verkar globalt och produkterna säljs via onlinekanaler, djuraffärer, veterinärer och dagligvaruhandel. Swedencare grundades år 1993 och har sitt huvudkontor i Malmö.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Swedencare appoints Kristy Murphy as Interim CEO of Naturvet

2026-11-04 08:30:00

Swedencare announces that, effective today, Kristy Murphy, Chief Revenue Officer, has been appointed Interim CEO of NaturVet succeeding Geoff Granger, who will leave his position as CEO with immediate effect.

Alongside her role as interim CEO, Kristy Murphy will continue to lead the commercial team and strategy. She brings more than 20 years of commercial leadership experience within the pet care and consumer goods industries. Prior to joining Swedencare, she held senior commercial positions at Made by Nacho, Simply Protein for Pets and Solid Gold Pet, following nine years with Mars. Her experience spans commercial strategy, sales, pricing, go-to-market execution and building high-performing teams across multiple retail channels and e-commerce. 

Since joining Swedencare in February this year, Kristy has played a key role in the planning and execution of the turnaround of the NaturVet brand and its private label business, with a strong focus on commercial execution, customer development and profitable growth.

“Kristy combines extensive industry experience with strong commercial leadership and a proven ability to drive change. The progress we have made with NaturVet and our private label business demonstrates her ability to translate strategy into execution and results. She knows our customers, our brands and our organization well, and I am very pleased that she has agreed to take on the role as Interim CEO. Our focus remains on accelerating organic growth, improving profitability and continuing to strengthen our North American business.

I also want to take the opportunity to thank Geoff for his important contributions to NaturVet and Swedencare during his time with the Group. Geoff has been a valued part of our North American organization, and I sincerely appreciate his commitment, leadership and hard work over the years. We wish him every success in the next chapter of his career,” says Håkan Lagerberg, CEO of Swedencare.